+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Biosimilar"

Psoriasis Biosimilars Market Report 2026 - Product Thumbnail Image

Psoriasis Biosimilars Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Biologic & Biosimilar RA Drugs Market Report 2026 - Product Thumbnail Image

Biologic & Biosimilar RA Drugs Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Oral Biologics & Biosimilar Drugs Market Report 2026 - Product Thumbnail Image

Oral Biologics & Biosimilar Drugs Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Oral Biologics & Biosimilars Market Report 2026 - Product Thumbnail Image

Oral Biologics & Biosimilars Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Immunology Biosimilars Market Report 2026 - Product Thumbnail Image

Immunology Biosimilars Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
From
From
From
From
From
MENA Biologics and Biosimilars Market Outlook 2026-2034 - Product Thumbnail Image

MENA Biologics and Biosimilars Market Outlook 2026-2034

  • Report
  • November 2026
  • 160 Pages
  • Africa, Middle East
From
The Global Industrial Biomanufacturing Market 2027-2037 - Product Thumbnail Image

The Global Industrial Biomanufacturing Market 2027-2037

  • Report
  • August 2026
  • 635 Pages
  • Global
From
The Global Synthetic Biology & Biomanufacturing Market 2026-2036 - Product Thumbnail Image

The Global Synthetic Biology & Biomanufacturing Market 2026-2036

  • Report
  • December 2025
  • 1135 Pages
  • Global
Biologics API Market  - Trends and Forecast Till 2035 - Product Thumbnail Image

Biologics API Market - Trends and Forecast Till 2035

  • Report
  • October 2026
  • 209 Pages
  • Global
From
Loading Indicator

The Biosimilar market is a subset of the biotechnology industry that focuses on the development and production of biologic drugs that are similar to existing biologic drugs. Biosimilars are created using a process called recombinant DNA technology, which involves the manipulation of genetic material to create a drug that is similar to an existing biologic drug. Biosimilars are typically used to treat chronic conditions such as cancer, rheumatoid arthritis, and multiple sclerosis. Biosimilars are typically cheaper than their brand-name counterparts, making them an attractive option for patients and healthcare providers. Some companies in the Biosimilar market include Amgen, Biocon, Celltrion, Dr. Reddy's Laboratories, Mylan, Pfizer, Sandoz, and Teva Pharmaceuticals. Show Less Read more